Kodiak Sciences (KOD) Current Assets (2017 - 2026)
Kodiak Sciences (KOD) reported Current Assets of $175.3 million for Q1 2026, up 22.83% on a YoY basis from $142.7 million in Q1 2025, and down 18.41% quarter-over-quarter from $214.8 million in Q4 2025.
Kodiak Sciences (KOD) Current Assets (2017 - 2026) Analysis & Trends
Kodiak Sciences has reported Current Assets for 10 years, with the latest figure at $175.3 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 22.83% year-over-year to $175.3 million; the trailing twelve-month figure through Mar 2026 stood at $175.3 million (up 22.83% YoY), and the FY2025 full-year result was $214.8 million, up 24.94% from the prior year.
- Current Assets for Q1 2026 stood at $175.3 million, down from $214.8 million in the prior quarter.
- The five-year high for Current Assets was $682.2 million in Q1 2022, with the low at $75.7 million in Q3 2025.
- Historically, Current Assets has averaged $314.3 million across 5 years, with a median of $251.5 million in 2024.
- The largest YoY upside for Current Assets was 24.94% in 2025 against a maximum downside of 62.6% in 2025.
- Kodiak Sciences' Current Assets stood at $486.0 million in 2022, then tumbled by 40.47% to $289.3 million in 2023, then sank by 40.57% to $171.9 million in 2024, then grew by 24.94% to $214.8 million in 2025, then retreated by 18.41% to $175.3 million in 2026.
- The last three Current Assets figures came in at $175.3 million (Q1 2026), $214.8 million (Q4 2025), and $75.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 600.85 Mn |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | 175.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 175.26 Mn |
| Dec 31, 2025 | 214.82 Mn |
| Sep 30, 2025 | 75.73 Mn |
| Jun 30, 2025 | 107.92 Mn |
| Mar 31, 2025 | 142.69 Mn |
| Dec 31, 2024 | 171.94 Mn |
| Sep 30, 2024 | 202.49 Mn |
| Jun 30, 2024 | 224.63 Mn |
| Mar 31, 2024 | 251.51 Mn |
| Dec 31, 2023 | 289.31 Mn |
| Sep 30, 2023 | 350.93 Mn |
| Jun 30, 2023 | 386.96 Mn |
| Mar 31, 2023 | 431.12 Mn |
| Dec 31, 2022 | 486.01 Mn |
| Sep 30, 2022 | 544.66 Mn |
| Jun 30, 2022 | 604.37 Mn |
| Mar 31, 2022 | 682.19 Mn |
| Dec 31, 2021 | 734.81 Mn |
| Sep 30, 2021 | 805.51 Mn |
| Jun 30, 2021 | 884.33 Mn |